| Product Code: ETC8704788 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Pakistan Antimicrobial Resistance Market Overview |
3.1 Pakistan Country Macro Economic Indicators |
3.2 Pakistan Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Pakistan Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Pakistan Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Pakistan Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Pakistan Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Pakistan Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Pakistan Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Pakistan Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Pakistan |
4.2.2 Growing awareness about the overuse of antibiotics and its consequences |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Lack of stringent regulations and enforcement to control antibiotic use |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Lack of awareness and education among the general population about antimicrobial resistance |
5 Pakistan Antimicrobial Resistance Market Trends |
6 Pakistan Antimicrobial Resistance Market, By Types |
6.1 Pakistan Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Pakistan Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Pakistan Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Pakistan Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Pakistan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Pakistan Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Pakistan Antimicrobial Resistance Market Export to Major Countries |
7.2 Pakistan Antimicrobial Resistance Market Imports from Major Countries |
8 Pakistan Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage increase in antibiotic stewardship programs in healthcare facilities |
8.2 Number of public health campaigns focused on educating the public about the responsible use of antibiotics |
8.3 Rate of adoption of alternative therapies to antibiotics in healthcare settings |
9 Pakistan Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Pakistan Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Pakistan Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Pakistan Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Pakistan Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Pakistan Antimicrobial Resistance Market - Competitive Landscape |
10.1 Pakistan Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Pakistan Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here